Optimax Holdings BhdXKLS:0222 71 ROE % is 15.28% as of Mar. 2026, which is 36% below its 10-year median of 23.92. GuruFocus rates XKLS:0222 with a GF Score™ of 71/100 and a GF Value™ of RM0.76 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 626 Healthcare Providers & Services companies, Optimax Holdings Bhd ranks better than 81.79% on this metric.
The historical rank and industry rank for Optimax Holdings Bhd's ROE % or its related term are showing as below:
XKLS:0222'
s ROE % Range Over the Past 10 Years
Min: 16 Med: 23.92 Max: 51.75
Current: 18.07
During the past 10 years, Optimax Holdings Bhd's highest ROE % was 51.75%. The lowest was 16.00%. And the median was 23.92%.
XKLS:0222's ROE % is ranked better than 81.79% of 626
companies
in the Healthcare Providers & Services industry
Industry Median: 5.805
vs XKLS:0222: 18.07
Optimax Holdings Bhd (XKLS:0222) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Optimax Holdings Bhd's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Optimax Holdings Bhd ROE % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Optimax Holdings Bhd's ROE % distribution charts can be found below:
* The bar in red indicates where Optimax Holdings Bhd's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
ROE % is displayed in the 30-year financial page.
Optimax Holdings Bhd (XKLS:0222) has a ROE % of 15.28% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Optimax Holdings Bhd and its competitors. This is 36% below median its historical median of 23.92. Over the past decade, Optimax Holdings Bhd's ROE % has ranged from 16.00 to 51.75. According to the industry distribution chart, Optimax Holdings Bhd ranks #114 out of 626 companies in the Healthcare Providers & Services industry, placing it in the top 18.2%.
Is Optimax Holdings Bhd's ROE % too high?
Optimax Holdings Bhd's current ROE % of 15.28% is 36% below median its 10-year median of 23.92. Over the past 10 years, this metric has ranged from a low of 16.00 to a high of 51.75. The Healthcare Providers & Services industry median ROE % is 5.81. Optimax Holdings Bhd's value of 15.28% is 163.2% above this industry median. Based on the distribution chart, Optimax Holdings Bhd ranks #114 out of 626 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Optimax Holdings Bhd has a GF Score™ of 71/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Optimax Holdings Bhd's ROE % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Optimax Holdings Bhd ranks #114 out of 626 companies for ROE %. This places Optimax Holdings Bhd in the top 18% of its industry — outperforming the majority of peers. The industry median ROE % is 5.81. Optimax Holdings Bhd's value of 15.28% is 163.2% above this benchmark. Historically, Optimax Holdings Bhd's own ROE % has ranged from 16.00 to 51.75 over the past decade. While the company's 10-year median is 23.92 vs. the industry median of 5.81, Optimax Holdings Bhd has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Healthcare Providers & Services company?
The median ROE % among Healthcare Providers & Services companies is 5.81, based on 626 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Optimax Holdings Bhd's current ROE % of 15.28% is 163.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Optimax Holdings Bhd and its competitors. For the Healthcare Providers & Services industry, the median ROE % is 5.81 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Optimax Holdings Bhd's current ROE % is 15.28%, which is 36% below median its own 10-year median of 23.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Optimax Holdings Bhd stock overvalued right now?
Based on GuruFocus' analysis, Optimax Holdings Bhd (XKLS:0222) is currently considered Significantly Undervalued. The stock's GF Value™ is RM0.76, compared to a current price of RM0.53 — trading 30.9% below its estimated fair value. The current ROE % is 15.28%, which is 36% below median its 10-year median of 23.92 and 163.2% above the Healthcare Providers & Services industry median of 5.81. Optimax Holdings Bhd's overall GF Score™ is 71/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Optimax Holdings Bhd (XKLS:0222), the current ROE % is 15.28% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Optimax Holdings Bhd (XKLS:0222) Overvalued in 2026?
Based on GuruFocus' analysis, Optimax Holdings Bhd stock appears to be undervalued.
The current stock price of RM0.53 is trading 30.9% below its estimated GF Value™ of RM0.76.
GuruFocus considers Optimax Holdings Bhd to be Significantly Undervalued.
Key valuation signals for XKLS:0222:
ROE %: 15.28% (36% below median its 10-year median of 23.92)
GF Value™: RM0.76 vs. price of RM0.53 (30.9% below fair value)
Industry Position: 163.2% above the Healthcare Providers & Services median (#114 of 626)
No single metric tells the full story. See the XKLS:0222 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Optimax Holdings Bhd is a provider of eye specialist services. The company offers a range of services with in-house medical ophthalmology at specialist centres such as specialist clinics, ambulatory care centres, satellite clinics, and specialist hospitals. The company's ambulatory care centres and specialist hospital are equipped with eye operation theatres, and procedure rooms, general and day care wards, and relevant equipment for surgical procedures. It derives revenue from refractive surgery, treatment of eye diseases and disorders, consultation and dispensary services, oculoplastic surgery, plastic Surgery and aesthetic Services and related services. The company operates in geographical segments such as: North Malaysia, Central Malaysia, South Malaysia, East Malaysia and Cambodia.
71GF Score
Get the complete analysis for XKLS:0222
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:0222 has been successfully added to your 
